Literature DB >> 23809421

Noncardiac comorbidities and acute heart failure patients.

Robert J Mentz1, G Michael Felker.   

Abstract

The acute heart failure (AHF) population is a heterogeneous group with multiple interrelated noncardiovascular comorbidities. Chronic obstructive pulmonary disease, renal disease, diabetes, sleep apnea, and anemia affect the clinical characteristics and outcomes of patients with AHF and complicate inpatient management. This article summarizes the impact of these noncardiovascular comorbidities in patients with AHF. In some circumstances, careful attention to the diagnosis and management of these conditions in patients with AHF may help to improve patient outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23809421      PMCID： PMC3906631          DOI： 10.1016/j.hfc.2013.04.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  72 in total

1.  High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.

Authors:  J Thomas Heywood; Gregg C Fonarow; Maria Rosa Costanzo; Vandana S Mathur; John R Wigneswaran; Janet Wynne
Journal:  J Card Fail       Date:  2007-08       Impact factor: 5.712

2.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Authors:  Marvin A Konstam; Mihai Gheorghiade; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Journal:  JAMA       Date:  2007-03-25       Impact factor: 56.272

3.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

Review 4.  Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

Authors:  Kevin Damman; Gerjan Navis; Adriaan A Voors; Folkert W Asselbergs; Tom D J Smilde; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege
Journal:  J Card Fail       Date:  2007-10       Impact factor: 5.712

Review 5.  Anemia and chronic heart failure implications and treatment options.

Authors:  Inder S Anand
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

6.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

7.  Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.

Authors:  Jalal K Ghali; Inder S Anand; William T Abraham; Gregg C Fonarow; Barry Greenberg; Henry Krum; Barry M Massie; Scott M Wasserman; Marie-Louise Trotman; Yan Sun; Beat Knusel; Paul Armstrong
Journal:  Circulation       Date:  2008-01-14       Impact factor: 29.690

8.  Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  Barry H Greenberg; William T Abraham; Nancy M Albert; Karen Chiswell; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young; Gregg C Fonarow
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

9.  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.

Authors:  Dirk J van Veldhuisen; Kenneth Dickstein; Alain Cohen-Solal; Dirk J A Lok; Scott M Wasserman; Nigel Baker; Dylan Rosser; John G F Cleland; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2007-08-06       Impact factor: 29.983

Review 10.  The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Heart Fail Rev       Date:  2008-02-02       Impact factor: 4.214
View more
  19 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

Review 2.  Sleep-disordered breathing in patients with heart failure.

Authors:  Robert J Mentz; Mona Fiuzat
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

Review 3.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

4.  COPD in heart failure: are there long-term implications following acute heart failure hospitalization?

Authors:  Lauren B Cooper; Robert J Mentz
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 5.  Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications.

Authors:  Christine Chow; Robert J Mentz; Stephen J Greene
Journal:  Curr Heart Fail Rep       Date:  2021-04-09

6.  Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.

Authors:  Takeshi Kitai; Justin L Grodin; Yong-Hyun Kim; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

7.  Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial.

Authors:  Adam Z Banks; Robert J Mentz; Amanda Stebbins; Catherine R Mikus; Phillip J Schulte; Jerome L Fleg; Lawton S Cooper; Eric S Leifer; Dalynn T Badenhop; Steven J Keteyian; Ileana L Piña; Dalane W Kitzman; Mona Fiuzat; David J Whellan; William E Kraus; Christopher M O'Connor
Journal:  J Card Fail       Date:  2015-12-11       Impact factor: 5.712

8.  Trends in prevalence of comorbidities in heart failure clinical trials.

Authors:  Muhammad Shahzeb Khan; Ayman Samman Tahhan; Muthiah Vaduganathan; Stephen J Greene; Alaaeddin Alrohaibani; Stefan D Anker; Orly Vardeny; Gregg C Fonarow; Javed Butler
Journal:  Eur J Heart Fail       Date:  2020-04-15       Impact factor: 15.534

9.  Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.

Authors:  Marat Fudim; Jennifer White; Neha J Pagidipati; Yuliya Lokhnygina; Julio Wainstein; Jan Murin; Nayyar Iqbal; Peter Öhman; Renato D Lopes; Barry Reicher; Rury R Holman; Adrian F Hernandez; Robert J Mentz
Journal:  Circulation       Date:  2019-09-23       Impact factor: 29.690

Review 10.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.